M. Rutten

POST-TREATMENT WITH THE NOVEL DELTORPHIN E, A &dgr;2-OPIOID RECEPTOR AGONIST, INCREASES RECOVERY AND SURVIVAL AFTER SEVERE HEMORRHAGIC SHOCK IN BEHAVING RATS

J. S. Sonneborn, P. Oeltgen, M. Rutten, 2007, Shock.

The drop in reported invasive pneumococcal disease among adults during the first COVID-19 wave in the Netherlands explained.

H. Wertheim, A. Post, B. Mulder, 2021, International Journal of Infectious Diseases.

Acute Therapeutic Use of 5-Aminoimidazole-4-Carboxamide Ribonucleoside Extends Survival Interval in Response to Severe Hemorrhagic Shock

M. Rutten, Joan Smith Sonneborn, 2011, Shock.

Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature.

A. Zwinderman, H. Keizer, F. Rosendaal, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute Therapeutic Use of 5-Aminoimidazole-4-Carboxamide Ribonucleoside Extends Survival Interval in Response to Severe Hemorrhagic Shock

M. Rutten, Joan Smith Sonneborn, 2011, Shock.